Age Verification
This website contains hemp-derived cannabinoid products.
You must be 21 years of age or older to enter.
By entering you confirm you are of legal age in your jurisdiction. Farm Bill 2018 compliant. For adults 21+ only.
Wellness Research & Education
Therapeutic Wellness Guide
Explore the emerging science behind cannabinoid therapy for various conditions. Our comprehensive guide covers the latest research, mechanisms of action, and how Xtono's premium exotic products may support your wellness journey.
PTSD
Post-Traumatic Stress Disorder
Overview
Post-Traumatic Stress Disorder affects millions worldwide, characterized by intrusive memories, hyperarousal, avoidance behaviors, and negative changes in mood and cognition. Traditional treatments include therapy and pharmaceutical interventions, but many patients seek complementary approaches.
How Cannabinoids May Help
The endocannabinoid system plays a critical role in fear extinction — the process by which traumatic memories lose their emotional charge. Cannabinoid compounds like THC-A and THC-P may support this process by modulating CB1 receptor activity in the amygdala and prefrontal cortex, areas central to fear processing and emotional regulation.
Research & Studies
A 2019 study in the Journal of Psychopharmacology found that cannabinoid-based therapies reduced nightmare frequency and improved overall sleep quality in PTSD patients.
Research published in Neuropharmacology demonstrated that cannabinoids facilitated fear extinction in animal models, suggesting potential for trauma processing.
A 2020 retrospective study showed 67% of PTSD patients reported symptom improvement with cannabinoid supplementation.
Common Symptoms
Recommended Products
Autism Spectrum
Autism Spectrum Disorder (ASD)
Overview
Autism Spectrum Disorder encompasses a range of neurodevelopmental conditions characterized by differences in social communication, sensory processing, and behavioral patterns. Many individuals on the spectrum experience co-occurring conditions including anxiety, sensory overload, and sleep difficulties.
How Cannabinoids May Help
Emerging research suggests the endocannabinoid system may be dysregulated in individuals with ASD. Cannabinoid compounds may help modulate sensory processing, reduce anxiety-driven behaviors, and support emotional regulation through interaction with CB1 and CB2 receptors throughout the nervous system.
Research & Studies
A landmark 2019 Israeli study published in Scientific Reports found that cannabis-based therapy improved behavioral symptoms in 80% of ASD participants.
Research in the Journal of Autism and Developmental Disorders showed cannabinoid treatment reduced self-injurious behavior and improved communication.
A 2021 systematic review identified promising evidence for cannabinoid-based interventions in managing ASD-associated anxiety and sleep disturbances.
Common Symptoms
Recommended Products
ADHD
Attention Deficit Hyperactivity Disorder
Overview
ADHD is a neurodevelopmental disorder affecting attention, impulse control, and executive function. While stimulant medications are the standard treatment, many adults seek alternative or complementary approaches due to side effects or incomplete symptom relief.
How Cannabinoids May Help
The endocannabinoid system modulates dopamine signaling — the same neurotransmitter pathway implicated in ADHD. Cannabinoid compounds may help regulate dopamine release and reuptake, potentially improving sustained attention, reducing impulsivity, and supporting executive function.
Research & Studies
A 2017 randomized controlled trial in European Neuropsychopharmacology found cannabinoids improved hyperactivity/impulsivity symptoms in adult ADHD patients.
Observational studies suggest certain cannabinoid profiles may enhance focus and reduce restlessness without the appetite suppression common with stimulant medications.
Research in the Journal of Psychopharmacology indicated that cannabinoid therapy may be particularly beneficial for ADHD patients with co-occurring anxiety.
Common Symptoms
Recommended Products
Anxiety Disorders
Generalized Anxiety, Social Anxiety & Panic Disorders
Overview
Anxiety disorders are among the most prevalent mental health conditions, affecting over 300 million people globally. Symptoms range from persistent worry and social avoidance to debilitating panic attacks. Many patients find traditional anxiolytics insufficient or accompanied by unwanted side effects.
How Cannabinoids May Help
Cannabinoid compounds interact with serotonin receptors (5-HT1A) and the endocannabinoid system to modulate the stress response. THC-A's non-psychoactive profile makes it particularly suitable for anxiety management, while specific terpene profiles in premium flower may enhance anxiolytic effects through the entourage effect.
Research & Studies
A comprehensive review in Neurotherapeutics found substantial evidence for cannabinoid-based anxiolytic effects across multiple anxiety disorder subtypes.
Clinical trials have demonstrated that cannabinoid compounds reduce anxiety scores in both social anxiety disorder and generalized anxiety disorder.
Preclinical studies show cannabinoids modulate fear and anxiety circuits in the amygdala and prefrontal cortex.
Common Symptoms
Recommended Products
Chronic Pain
Chronic Pain & Inflammatory Conditions
Overview
Chronic pain affects an estimated 1.5 billion people worldwide and is a leading cause of disability. Conditions include fibromyalgia, neuropathic pain, arthritis, and inflammatory disorders. The opioid crisis has intensified the search for effective, non-addictive pain management alternatives.
How Cannabinoids May Help
The endocannabinoid system is one of the body's primary pain modulation pathways. Cannabinoid compounds activate CB1 and CB2 receptors to reduce pain signaling, decrease inflammation, and modulate the perception of pain. THC-P's enhanced receptor binding affinity may provide particularly effective pain relief.
Research & Studies
The National Academies of Sciences, Engineering, and Medicine concluded there is substantial evidence that cannabis is effective for treating chronic pain in adults.
A meta-analysis in the Journal of Pain Research found cannabinoid therapy reduced chronic pain intensity by an average of 30% compared to placebo.
Research shows cannabinoids may reduce opioid consumption when used as adjunctive therapy for chronic pain management.
Common Symptoms
Recommended Products
Sleep Disorders
Insomnia & Sleep Quality Disorders
Overview
Sleep disorders affect approximately 70 million Americans, with insomnia being the most common. Poor sleep quality impacts cognitive function, immune health, emotional regulation, and overall quality of life. Many sleep medications carry risks of dependency and next-day impairment.
How Cannabinoids May Help
Cannabinoid compounds influence sleep-wake cycles through multiple mechanisms: CB1 receptor activation in the hypothalamus modulates circadian rhythm signaling, while certain cannabinoid profiles may increase adenosine levels to promote sleep onset. The entourage effect of full-spectrum flower may be particularly beneficial for sleep.
Research & Studies
A large-scale observational study found that 71% of participants reported improved sleep quality with cannabinoid supplementation.
Research in the Journal of Clinical Pharmacology demonstrated that cannabinoids reduced sleep latency and increased total sleep time.
Studies indicate cannabinoid therapy may be particularly effective for sleep disturbances secondary to chronic pain and PTSD.
Common Symptoms
Recommended Products
Important Disclaimer
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. The information provided on this page is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional before starting any new supplement regimen, especially if you have a pre-existing medical condition or are taking medication. Individual results may vary. All products are derived from hemp and contain ≤0.3% Delta-9 THC on a dry weight basis, in compliance with the Agriculture Improvement Act of 2018 (Farm Bill).